Virus Recombinant Vaccines Flashcards

1
Q

Goals of vaccination against viruses

A

Induce immunity in individual hosts that…
Prevent or eliminates viral disease
Causes no or minimal associated morbidity or mortality.

Induce “herd” immunity that …
Greatly restricts virus circulation in a given community
Protects vulnerable members of the community for whom the vaccine is proscribed

Virus eradication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do vaccines work?

A

Vaccine antigen introduced to body (Mucosal or Parenteral) -> Viral antigen taken up by APCs -> present antigen to B and T cells in correct conformation in LNs -> Clonal expansion of epiptope-specific memory B and T cells -> Accelerated response to virus upon infection -> protection from disease due to Tc cells and neutralising Abs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary and memory Ig responses - basis of vaccination

A

1st infection/vaccination - 1º response
2nd exposure - anamnestic response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are epitopes?

A

Antigenic determinants of molecules that are bound by:
Antibodies (B cell epitopes) - Peptides, polysaccharides, lipids
T cell receptors (T cell epitopes) = Peptides

Dominant epitopes = Elicit strongest immune responses
Subdominant epitopes = Less immunogenic than dominant epitopes

Viruses direct immune system to dominant epitopes but AREN’T essential and there can be subdominant epitopes = essential (eg part of receptor binding site)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

B cell Epitopes can be

A

Linear peptides
Contiguous chain of amino acids within a protein
Antibodies can recognise primary structures

Conformational peptides
Non-contiguous chains of amino acids within a protein (3º structure)
Antibody recognition dependent of tertiary folding of protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Peptide scanning (pepscans) for linear B cell epitopes

A

Synthase overlapping peptides with 1 more peptide at end and 1 less at start. Add to wells and add antibodies to identify which peptides contain the epitope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Examples of T cell Epitopes

A

T helper cells (CD4+)
- Linear peptides
- Presented by MHC class II

Cytotoxic T cells (CD8+)
- Linear peptides
- Presented by MHC class I

T regulatory cells (CD4+CD25+)
- dampen down response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antigen-Specific T and B cell maturation and function

A

Cytokines and chemokines induced following infection
APC interacts with Th0 cell to produce IL-2 - Th2 response - drives towards Th response
Th1 - drives towards t cytotoxic cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Current recombinant viral vaccine strategies

A

Live attenuated viruses
Recombinant subunit vaccines
Virus vectors expressing viral vaccine antigens
DNA vaccines
Edible plants expressing viral vaccine antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Strategy and rationale of live attenuated viruses

A

Cold adapted, temperature sensitive:
Multiple passages at progressively lower temps
Restricted growth at 37ºC

Mucosal administration - Mucosal and systemic antibody and T cell responses
Restrict virus replication to upper respiratory tract
- Eliminate virus pathogenesis for lower respiratory tract by restricting growth at 37ºc

Eg Influenza virus and RSV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Edible vaccines

A

Genetically modified plants expressing viral vaccine antigens
Consumption induces immune responses in intestine = mucosal immunity
- Processing of antigens through M cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Do edible vaccines work? 🥔

A

Potato expressing hepatitis B surface antigen (HBsAg)

Double blind placebo controlled trial

  • Consumption by previously vaccinated individuals
    -Recombinant potatoes expressing HBsAg
    -Recombinant potatoes with no antigen
  • Detection of boosts in anti-HBsAg titres in serum following vaccination.
    -Surrogate of protective immunity

Conclusions:
- consumption of HBsAg potatoe increases antibody titres
- edible vaccines have potential in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why continue research on influenza virus vaccines?

A

Current split/subunit vaccine
Limited heterosubtypic immunity
Vaccine efficacy based on antibody responses
- Antigenic drift = new vaccines required each year
- Antigenic shift may eliminate vaccine efficacy

Rationale:
Search for novel influenza vaccine antigens that
- Induce strong heterosubtypic immunity
- Both B and T cell based
- Reduce/eliminate necessity to change vaccine yearly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Principle of DNA vaccines

A

Viral antigen expression from DNA plasmids delivered directly to host
Precision plasmid can be generated eg:
- vaccine antigen
- specific promoters
- codon optimisation
- immune enhancing genes
-cytokines/chemokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

5 considerations(steps) in production of a DNA vaccine

A

Plasmid optimisation
Gene optimisation
Formulation adjuvants
Immune plasma adjuvants
Delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Live attenuated RSV vaccines - strategy, alternative strategy and major obstacle

A

Cold adapted, temperature sensitive strategy:
Failure to find appropriate balance between immunogenicity and pathogenicity in infants
- Non-pathogenic with insufficient immunogenicity
- Unacceptable pathogenicity with reasonable immunogenicity

Alternative strategy = Remove virulence factors from virus
ΔNS1 +/- ΔNS2 +/- ΔSH genes
Re-entered clinical trials

Major obstacle = Natural infection does not induce long term immunity

17
Q

Do DNA vaccines work?

A

Yes. Proven in mice not humans.
Some died?

18
Q

Recombinant viral vectors (3)

A

Herpes viruses (HSV 1)
Alpha viruses (SFV,EEV)
Paramyxoviridae (Sendai virus)

19
Q

Production of rSeV

A

Reverse genetic system to produce cDNA and place in plasmid
Manipulate the genome
Insert RSVf
Express RSV F
Promoter pT7 drives transcription
Helper things - plasmids encoding L,N,P proteins (polymerase complex) responsible for nucleocapsid production

20
Q

3 steps of recombinant viral subunit vaccines

A

Identification of potential vaccine antigens
In silico T and B cell epitope candidate identification
Pepscan analysis for T cell proliferation and antibody ELISA reactivity

Antigen production
Bacteria, Eukaryotic cells, Recombinant baculovirus infection of insect cells, Yeast

Vaccine formulation
Antigen + adjuvant

Pre-clinical testing for induction of protective immunity
Rodents, Non-human primates

21
Q

Does rSeV/RSV F have vaccine potential against RSV?

A

YES = bivalent vaccine against RSV and hPIV1
Strong Ab response - RSVF?

22
Q

Protective/immunogenic responses to RSV proteins

A

F and G
M2 had epitope v good at inducing response
IDK

23
Q

Major problems with RSV vaccine models

A

Closer to humans - diminished
What happens to mouse not that similar to humans probably. Once again. Idk

Species specificity

24
Q

Recombinant viral subunit vaccine formulation has…

A

Very limited choice of adjuvants
Aluminium hydroxide
Aluminium phosphate
MF59

Major research efforts underway to identify new adjuvants
Pathogen recognition receptor agonists
-TLR agonists
- NLR agonists
- MDA5/RIG-I agonists

25
Q

Major problem and solution for HIV and HCV recombinant subunit vaccines

A

Massive strain variation
- major vaccine antigens highly variable

Solution = Vaccine strategies
- generation of recombinant subunit vaccines derived from multiple strains
- identification of vaccine antigens capable of inducing heterosubtypic immunity

26
Q

SARS-CoV-2 vaccine

A

20 years of research into mRNA vaccine
10 years into fusion proteins
Vaccine aims to stop conformational change of spike protein

Wasn’t a fun time- all you need to know x

  • Holly Drummond, SARS-CoV-2 survivor and expert in all things biomedical, especially biomedical science. (Not a biomedical scientist at time of publication)
27
Q

How to decide which vaccines to recombinate?

A

Safety
Live attenuated most effective but may be less safe compared to ones containing inactive viruses or part of a virus

28
Q

Kids breathe through their_____.

A

👃

29
Q

Production of mRNA vaccine

A

Remove ability to stimulate immune response
Mutate to make it more stable
Labile
-> produce delivery package - liposome encapsulates RNA

Protects against severe disease and diminishes transmission

30
Q

MAb against SARS-CoV-2

A

Virus mutated to make these ineffective
New MAb was able to neutralise all variants
-> therefore one epiptope
=> hopeful for vaccine